Skip to main content
OpenTrials
Completed

NCT Number: NCT02502682

Chlorhexidine Bathing Effect on Clostridium Difficile Rates

Clostridium difficile (C. diff.) infections, whether nosocomial or community borne, may present with profound diarrhea, especially in those patients receiving antibiotics. Based on a preliminary review of hospital data, the investigators have found that these symptomatic c. diff infections occur with a relatively high incidence at Delnor Hospital. Notwithstanding their high mortality, one recent study attributes a near quadrupling of hospitalization costs to c. diff infections. Chlorhexidine baths have been shown in multiple randomized trials to help reduce the incidence of highly virulent pathogens and hospital acquired infections. Further, several studies show a favorable effect of reducing the incidence of c. diff infections by using Chlorhexidine baths on ICU patients. Far fewer studies, however, have focused on the effects of these baths on general medical/surgical wards. This investigation seeks to study the effect of the daily use of 2% Chlorhexidine gluconate wipes in patients on the general medical/surgical wards who are exposed to antibiotics for a suspected or confirmed infection.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Northwestern Medicine - Delnor Hospital

Geneva, Illinois, 60134, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Prescription of antibiotics for suspected or confirmed infection.
  • Admitted to the 2600 General/Medical ward at Delnor Hospital.

Exclusion criteria

  • Antibiotics only for surgical prophylaxis
  • Not mentally capable
  • Cannot provide consent in English
  • Pregnant
  • Documented chlorhexidine allergy
  • Patient is a prisoner
  • Health system employee

Treatment and study plan

Sage 2% Chlorhexidine Gluconate Cloth Patient Preoperative Skin Preparation

Drug

Daily bathing.

Primary outcomes

  1. Number of participants with Relative Risk of C-diff infection

    Time frame: up to 12 months

    Study data will cease to be collected after 300 participants have been enrolled or until 12 months have elapsed. Data will be collected and assessed monthly.

  2. Duration of Hospital stays

    Time frame: expected average of six days

Sponsors and collaborators

Lead sponsor

Jared Brooks

Other

Collaborators

  • Northwestern Medicine

Registry information

Official study title

Effect of Daily Chlorhexidine Bathing on Clostridium Difficile Rates on the General Medical Floor in Patients Receiving Antibiotics

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Jul 20, 2015
Registry last updated
Jul 11, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.